Melanoma and Immunotherapeutics Service Chief Jedd Wolchok shared his thoughts on updated research that shows that the effects of drug-based immunotherapy can sometimes last for years in patients who were treated for advanced melanoma.
Medical oncologist Michael Morris was interviewed about a new study that found that men given chemotherapy early in their treatment for advanced prostate cancer lived longer than those who did not get early chemotherapy.
Physician-in-Chief José Baselga was interviewed about Memorial Sloan Kettering’s collaboration with Quest Diagnostics to screen patients’ cancer genes and help doctors choose the best treatments. Memorial Sloan Kettering’s Marc Ladanyi, David Solit and Charles Sawyers were also interviewed.
Breast cancer surgeon Tari King discussed a study that showed that most women who have a double mastectomy after a breast cancer diagnosis do so despite a very low risk of developing cancer in the healthy breast.